Overview

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women

Status:
Completed
Trial end date:
2019-07-08
Target enrollment:
Participant gender:
Summary
To demonstrate non-inferiority of FE 999049 compared to FOLLISTIM with respect to number of oocytes retrieved in Japanese IVF/ICSI patients undergoing controlled ovarian stimulation.
Phase:
Phase 3
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Follicle Stimulating Hormone